MedTrace Logo

tDCS in Pediatric Acquired Brain Injury

NCT03618849 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1

Last updated 2024-02-02

No results posted yet for this study

Summary

In this preliminary study, we will examine the safety, tolerability, and feasibility of transcranial direct current stimulation (tDCS), in the setting of dosage escalation, as a candidate intervention for children with Acquired Brain Injury (ABI).

Conditions

  • Acquired Brain Injury
  • Disorders of Consciousness

Interventions

DEVICE

tDCS

Real and sham tDCS/Mozart piano sonata (K.448)

Sponsors & Collaborators

Principal Investigators

  • Stacy J Suskauer, MD · Hugo W. Moser Research Institute at Kennedy Krieger, Inc.

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SEQUENTIAL

Eligibility

Min Age
5 Years
Max Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-08-01
Primary Completion
2024-01-31
Completion
2024-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03618849 on ClinicalTrials.gov